337 related articles for article (PubMed ID: 18832680)
1. CD4 T cell-mediated rejection of cardiac allografts in B cell-deficient mice.
Nozaki T; Rosenblum JM; Ishii D; Tanabe K; Fairchild RL
J Immunol; 2008 Oct; 181(8):5257-63. PubMed ID: 18832680
[TBL] [Abstract][Full Text] [Related]
2. Antibody-mediated rejection of cardiac allografts in CCR5-deficient recipients.
Nozaki T; Amano H; Bickerstaff A; Orosz CG; Novick AC; Tanabe K; Fairchild RL
J Immunol; 2007 Oct; 179(8):5238-45. PubMed ID: 17911609
[TBL] [Abstract][Full Text] [Related]
3. Alloreactive T cell responses and acute rejection of single class II MHC-disparate heart allografts are under strict regulation by CD4+ CD25+ T cells.
Schenk S; Kish DD; He C; El-Sawy T; Chiffoleau E; Chen C; Wu Z; Sandner S; Gorbachev AV; Fukamachi K; Heeger PS; Sayegh MH; Turka LA; Fairchild RL
J Immunol; 2005 Mar; 174(6):3741-8. PubMed ID: 15749914
[TBL] [Abstract][Full Text] [Related]
4. Immunobiology of allograft rejection in the absence of IFN-gamma: CD8+ effector cells develop independently of CD4+ cells and CD40-CD40 ligand interactions.
Bishop DK; Chan Wood S; Eichwald EJ; Orosz CG
J Immunol; 2001 Mar; 166(5):3248-55. PubMed ID: 11207279
[TBL] [Abstract][Full Text] [Related]
5. Absence of recipient CCR5 promotes early and increased allospecific antibody responses to cardiac allografts.
Amano H; Bickerstaff A; Orosz CG; Novick AC; Toma H; Fairchild RL
J Immunol; 2005 May; 174(10):6499-508. PubMed ID: 15879153
[TBL] [Abstract][Full Text] [Related]
6. IL-1 Receptor Signaling on Graft Parenchymal Cells Regulates Memory and De Novo Donor-Reactive CD8 T Cell Responses to Cardiac Allografts.
Iida S; Tsuda H; Tanaka T; Kish DD; Abe T; Su CA; Abe R; Tanabe K; Valujskikh A; Baldwin WM; Fairchild RL
J Immunol; 2016 Mar; 196(6):2827-37. PubMed ID: 26856697
[TBL] [Abstract][Full Text] [Related]
7. Analysis of the CD40 and CD28 pathways on alloimmune responses by CD4+ T cells in vivo.
Bingaman AW; Ha J; Durham MM; Waitze SY; Tucker-Burden C; Cowan SR; Pearson TC; Larsen CP
Transplantation; 2001 Oct; 72(7):1286-92. PubMed ID: 11602857
[TBL] [Abstract][Full Text] [Related]
8. Absence of allograft ICAM-1 attenuates alloantigen-specific T cell priming, but not primed T cell trafficking into the graft, to mediate acute rejection.
Zhang QW; Kish DD; Fairchild RL
J Immunol; 2003 Jun; 170(11):5530-7. PubMed ID: 12759430
[TBL] [Abstract][Full Text] [Related]
9. Long-term cardiac allograft survival across an MHC mismatch after "pruning" of alloreactive CD4 T cells.
Hu M; Watson D; Zhang GY; Graf N; Wang YM; Sartor M; Howden B; Fletcher J; Alexander SI
J Immunol; 2008 May; 180(10):6593-603. PubMed ID: 18453578
[TBL] [Abstract][Full Text] [Related]
10. CD4+ T cell recognition of a single discordant HLA-A2-transgenic molecule through the indirect antigen presentation pathway induces acute rejection of murine cardiac allografts.
Smith CR; Jaramillo A; Liu W; Tu Y; Kaleem Z; Swanson CJ; Mohanakumar T
Transplantation; 2001 Jun; 71(11):1640-8. PubMed ID: 11435977
[TBL] [Abstract][Full Text] [Related]
11. Natural killer cells play a critical role in mediating inflammation and graft failure during antibody-mediated rejection of kidney allografts.
Kohei N; Tanaka T; Tanabe K; Masumori N; Dvorina N; Valujskikh A; Baldwin WM; Fairchild RL
Kidney Int; 2016 Jun; 89(6):1293-306. PubMed ID: 27165816
[TBL] [Abstract][Full Text] [Related]
12. Donor IFN-gamma receptors are critical for acute CD4(+) T cell-mediated cardiac allograft rejection.
Wiseman AC; Pietra BA; Kelly BP; Rayat GR; Rizeq M; Gill RG
J Immunol; 2001 Nov; 167(9):5457-63. PubMed ID: 11673565
[TBL] [Abstract][Full Text] [Related]
13. Relative Frequencies of Alloantigen-Specific Helper CD4 T Cells and B Cells Determine Mode of Antibody-Mediated Allograft Rejection.
Alsughayyir J; Chhabra M; Qureshi MS; Mallik M; Ali JM; Gamper I; Moseley EL; Peacock S; Kosmoliaptsis V; Goddard MJ; Linterman MA; Motallebzadeh R; Pettigrew GJ
Front Immunol; 2018; 9():3039. PubMed ID: 30740108
[TBL] [Abstract][Full Text] [Related]
14. Prolonged allograft survival in anti-CD4 antibody transgenic mice: lack of residual helper T cells compared with other CD4-deficient mice.
Han WR; Zhan Y; Murray-Segal LJ; Brady JL; Lew AM; Mottram PL
Transplantation; 2000 Jul; 70(1):168-74. PubMed ID: 10919596
[TBL] [Abstract][Full Text] [Related]
15. Peptides derived from alpha-helices of allogeneic class I major histocompatibility complex antigens are potent inducers of CD4+ and CD8+ T cell and B cell responses after cardiac allograft rejection.
Shirwan H; Leamer M; Wang HK; Makowka L; Cramer DV
Transplantation; 1995 Feb; 59(3):401-10. PubMed ID: 7871571
[TBL] [Abstract][Full Text] [Related]
16. Antibody-mediated rejection of single class I MHC-disparate cardiac allografts.
Hattori Y; Bucy RP; Kubota Y; Baldwin WM; Fairchild RL
Am J Transplant; 2012 Aug; 12(8):2017-28. PubMed ID: 22578247
[TBL] [Abstract][Full Text] [Related]
17. Analysis of the role of negative T cell costimulatory pathways in CD4 and CD8 T cell-mediated alloimmune responses in vivo.
Ito T; Ueno T; Clarkson MR; Yuan X; Jurewicz MM; Yagita H; Azuma M; Sharpe AH; Auchincloss H; Sayegh MH; Najafian N
J Immunol; 2005 Jun; 174(11):6648-56. PubMed ID: 15905503
[TBL] [Abstract][Full Text] [Related]
18. The role of CD8 and CD4 T cells in intestinal allograft rejection: a comparison of monoclonal antibody-treated and knockout mice.
He G; Hart J; Kim OS; Szot GL; Siegel CT; Thistlethwaite JR; Newell KA
Transplantation; 1999 Jan; 67(1):131-7. PubMed ID: 9921809
[TBL] [Abstract][Full Text] [Related]
19. Novel CD8 T cell alloreactivities in CCR5-deficient recipients of class II MHC disparate kidney grafts.
Ishii D; Rosenblum JM; Nozaki T; Schenk AD; Setoguchi K; Su CA; Gorbacheva V; Baldwin WM; Valujskikh A; Fairchild RL
J Immunol; 2014 Oct; 193(7):3816-24. PubMed ID: 25172484
[TBL] [Abstract][Full Text] [Related]
20. Activation of alloreactive CD8+ T cells operates via CD4-dependent and CD4-independent mechanisms and is CD154 blockade sensitive.
Zhai Y; Meng L; Busuttil RW; Sayegh MH; Kupiec-Weglinski JW
J Immunol; 2003 Mar; 170(6):3024-8. PubMed ID: 12626556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
